Fertility care startup Arva Health has raised $1 million in a pre-seed funding round led by All In Capital, with participation from iSeed, Bharath Founders Fund, and Galaxy. The funding will support the launch of its network of tech-enabled fertility clinics, starting in Bengaluru.

Arva Health plans to expand its presence significantly, with a goal of opening clinics in ten locations, including Mumbai and Delhi, by 2027. In addition to its physical expansion, the company aims to introduce men’s fertility services and develop a digital platform to provide continuous fertility support.

Founded by Dipalie Bajaj and Nidhi Panchmal, Arva Health specializes in at-home blood tests designed to assess and track fertility. The company offers fertility testing services tailored for women with conditions such as PCOS and thyroid issues. Its clinically-backed AMH testing provides detailed insights into female fertility health, including egg reserve levels.

Arva Health’s first flagship clinic in Whitefield, Bengaluru, will offer a comprehensive range of fertility services, including testing, consultations, egg freezing, and IVF treatments. The company emphasizes a modern, judgment-free approach to fertility care, ensuring an improved patient experience.

“We are not in the business of diagnosing infertility but in the business of helping people have babies. By improving access and experience, we can dramatically improve outcomes for millions of people,” said Dipalie Bajaj, co-founder and CEO of Arva Health.

Since its inception last year, Arva claims to have assisted over 4,000 women in navigating their fertility journey, built a community of 40,000 members, and achieved a growth rate of 60% month-over-month. With its latest funding, the company is poised to redefine fertility care in India by integrating technology, accessibility, and patient-centered solutions.